Crystagen

Crystagen is a thymic-derived peptide bioregulator that modulates immune function, supports thymic repair, and enhances lymphocyte output. It is administered orally and has been shown in Eastern European research to improve immune performance in aging and immunosuppressed individuals.

• Normalizes thymus-derived peptide signaling pathways
• Stimulates lymphocyte differentiation and cytokine balance
• Restores immune regulatory gene expression in aged individuals

• unit: capsules

  low dose: 1

  frequency: Daily

  high dose: 3

  standard dose: 2

  administration route: Oral

• Typical course: 10–30 days of daily dosing. Repeat up to 2–3x per year for immune maintenance.

sequence: Ala-Glu-Asp-Gly

half life: Not published; effects persist through gene expression regulation

degradation: Metabolized via standard proteolytic peptide pathways

molecular weight: 467.57

molecular formula: C23H37N5O6

tissue specificity: Thymus, lymph nodes, and peripheral immune cells

• Molecular aspects of immunoprotective activity of peptides in spleen during the ageing process.preclinicalPMID 28976144 ↗